Alexandra A. Becker

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Midbody Positioning and Distance Between Daughter Nuclei Enable Unequivocal Identification of Cardiomyocyte Cell Division in Mice.

Midbody Positioning and Distance Between Daughter Nuclei Enable Unequivocal Identification of Cardiomyocyte Cell Division in Mice.

Journal: Circulation research

Published: October 26, 2018

Visualization of endothelial cell cycle dynamics in mouse using the Flt-1/eGFP-anillin system.

Visualization of endothelial cell cycle dynamics in mouse using the Flt-1/eGFP-anillin system.

Journal: Angiogenesis

Published: November 25, 2017

The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer.

The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: September 14, 2016

Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.

Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.

Journal: Human molecular genetics

Published: November 23, 2015

Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.

Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.

Journal: Journal of medical genetics

Published: November 17, 2015

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Journal: JAMA

Published: April 08, 2015

Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.

Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.

Journal: Human molecular genetics

Published: February 27, 2014

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families.

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families.

Journal: Breast cancer research : BCR

Published: December 24, 2013

Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.

Journal: Clinical chemistry

Published: November 12, 2013

Activating somatic FGFR2 mutations in breast cancer.

Activating somatic FGFR2 mutations in breast cancer.

Journal: PloS one

Published: November 02, 2012

Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.

Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction.

Journal: PloS one

Published: August 13, 2012

A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.

A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.

Journal: Breast cancer research and treatment

Published: January 30, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026